This is the second such partnership by an Indian company with RDIF. Earlier, Dr Reddy#39;s partnered with RDIF to conduct clinical trials, manufacturer and distribute 100 million doses of Sputnik V vaccine in India.RDIF and Hetero agree to produce over 100 million doses of Sputnik V COVID-19 vaccine in India
This is the second such partnership by an Indian company with RDIF. Earlier, Dr Reddy#39;s partnered with RDIF to conduct clinical trials, manufacturer and distribute 100 million doses of Sputnik V vaccine in India.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The bank plans to raise up to Rs 500 crore by issue of equity shares to qualified institutional buyers through qualified institutional plac...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment